ARCA Biopharma Shares Rise 22% Premarket; Co Announced on Thursday ASPEN-COVID-19 Data And Safety Monitoring Committee Recommends Continuing Phase 2b Clinical Trial To Completion Based On Interim Analysis Of Efficacy And Safety Data